Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tina, Maluso"'
Autor:
Tina Maluso, Regina A. Swift, Jason D. Nosrati, Eric Wirtschafter, Michael Ghermezi, Aleksandra Vidisheva, James R. Berenson, Sean Bujarski, Tanya M. Spektor, Kyle Udd, Zachary Gross, Benjamin Eades, Gary Cecchi, Ashkon Rahbari
Publikováno v:
European Journal of Haematology. 100:621-623
Objective To evaluate the efficacy and safety of elotuzumab and dexamethasone (Ed) for relapsed or refractory multiple myeloma (RRMM) patients. Method This retrospective study evaluated the efficacy and safety of (Ed) treatment for 21 RRMM patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f81be2a387df03177357afe657ef252a
https://doi.org/10.1111/ejh.13058
https://doi.org/10.1111/ejh.13058
Publikováno v:
In Journal of Pain and Symptom Management 2001 21(5):425-438
Autor:
Leonard M. Klein, Regina A. Swift, Robert Vescio, Laura Stampleman, Tanya M. Spektor, Alexa Cohen, Thomas B. S. Woliver, Peter Rosen, Tina Maluso, Alberto Bessudo, James R. Berenson, Shahrooz Eshaghian, Youram Nassir, Marshall S. Flam
Publikováno v:
British journal of haematology. 180(1)
Summary Immunomodulatory drugs including thalidomide, lenalidomide (LEN) and pomalidomide (POM), are effective for treating multiple myeloma (MM). POM has shown enhanced efficacy with dexamethasone (DEX). Pegylated liposomal doxorubicin (PLD) with bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f432b5d07ac048d070dc6a8ab90d9e0
https://pubmed.ncbi.nlm.nih.gov/29164606
https://pubmed.ncbi.nlm.nih.gov/29164606
Autor:
Youram Nassir, Regina A. Swift, Imad A. Tabbara, Joseph Z. Ye, James R. Berenson, Tina Maluso, Shahrooz Eshaghian, Mehdi M. Moezi, Sikander Ailawadhi, Jose Lutzky, Kyle Udd, James Wang, Tanya M. Spektor, Ronald G. Steis, Laura Stampleman, Aleksandra Vidisheva, Jacob D. Bitran
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25(10)
Neuropathy is an important complication that may limit treatment options for patients with multiple myeloma. Previous studies have focused on treatment efficacy and have shown that retreatment with bortezomib (BTZ) is an effective treatment option. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8efe02655f41649ab161c670f8e79507
https://pubmed.ncbi.nlm.nih.gov/28455546
https://pubmed.ncbi.nlm.nih.gov/28455546
Autor:
Roy Mackintosh, Nashat Y. Gabrail, Haresh S. Jhangiani, Robert Vescio, Alberto Bessudo, Ashkan Lashkari, James R. Berenson, Tanya M. Spektor, Michael Oren Robinson, Tina Maluso, Regina A. Swift, Samir V. Kubba, Jeffrey D. Neidhart, Alexa Cohen, Ibrahim Nakhoul
Publikováno v:
Journal of Clinical Oncology. 36:e20012-e20012
e20012Background: Pomalidomide (POM) is a third–generation immunomodulatory drug shown to be safe and effective for the treatment of relapsed/refractory multiple myeloma (RRMM) patients (pts) previ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8e2636c695ed7aa7a66c426b01ecd03
https://doi.org/10.1200/jco.2018.36.15_suppl.e20012
https://doi.org/10.1200/jco.2018.36.15_suppl.e20012
Autor:
Tina Maluso-Bolton
Publikováno v:
Journal of Oncology Practice. 2:289-293
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0af3583dda82c71aaf7dc751310fe79
https://doi.org/10.1200/jop.2.6.289
https://doi.org/10.1200/jop.2.6.289
Autor:
Tanya M. Spektor, Steven Jeffrey Hager, Mehdi M. Moezi, Robert A. Moss, Stephen Lim, Shahrooz Eshaghian, Alan Cartmell, Joseph Z. Ye, Tina Maluso, Alberto Bessudo, Regina A. Swift, G. Q. Chen, James R. Berenson, Jacob D. Bitran, Alexa Cohen, Teresa A. Coleman, John Stewart Hrom
Publikováno v:
Journal of Clinical Oncology. 35:8013-8013
8013 Background: The proteasome inhibitor (PI) ixazomib (Ixz) is the first orally administered PI approved for treating multiple myeloma (MM). It has shown clinical activity as a single agent and when used in other combinations. In this phase 1/2 tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1838bb90754c7d467c112fe440c90ecf
https://doi.org/10.1200/jco.2017.35.15_suppl.8013
https://doi.org/10.1200/jco.2017.35.15_suppl.8013
Autor:
Michael Oren Robinson, Tina Maluso, Nashat Y. Gabrail, Ashkan Lashkari, Alexa Cohen, Roy Mackintosh, Ibrahim Nakhoul, Samir V. Kubba, Jeffrey D. Neidhart, James R. Berenson, Shahrooz Eshaghian, Alberto Bessudo, Robert Vescio, Tanya M. Spektor, Regina A. Swift, Haresh S. Jhangiani
Publikováno v:
Journal of Clinical Oncology. 35:e19528-e19528
e19528 Background: Pomalidomide (POM) is a third –generation immunomodulatory drug shown to be safe and effective for the treatment of relapsed/refractory multiple myeloma (RRMM) for patients (pts) previously treated with bortezomib and lenalidomid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b78b66c1009b24c39046d83febf198b4
https://doi.org/10.1200/jco.2017.35.15_suppl.e19528
https://doi.org/10.1200/jco.2017.35.15_suppl.e19528
Publikováno v:
Journal of Pain and Symptom Management. 21:425-438
Donepezil, an oral acetylcholinesterase inhibitor approved for the treatment of Alzheimer's disease, was given to 6 cancer pain patients having sedation related to the analgesic use of opioids. Each patient was taking more than 200 mg of oral morphin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fad986f7c3c12757259e026e9f61a393
https://doi.org/10.1016/s0885-3924(01)00270-6
https://doi.org/10.1016/s0885-3924(01)00270-6
Autor:
Tina Maluso-Bolton
Publikováno v:
Journal of Hospice & Palliative Nursing. 2:9-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d453a9f050efdad0c6c36feb7bff471d
https://doi.org/10.1097/00129191-200002010-00004
https://doi.org/10.1097/00129191-200002010-00004